-
Most Popular
Biotech Stocks
Biotech is defined as using technology to change, manipulate, and harness biological processes in order to fulfill a medical need. The applications of biotech are endless and range from genetically modifying foods to creating vaccines. During the height of the coronavirus pandemic, companies like Moderna and BioNTech utilized biotech to create life-saving vaccines that were distributed across the globe.
7 Recession-Resistant Stocks to Hold Onto for Dear Life in 2024
These seven recession-resistant stocks offer stability and potential growth even in challenging economic conditions.
3 Promising Biotech Stocks for the Long-Term: August 2024
Some of the best biotech opportunities can be found in oversold obesity treatment stocks. Here are just a few.
The 3 Best Healthcare Stocks to Buy in August 2024
These are the best healthcare stocks that could bring in massive returns to the investors in the future. Do not miss out on this opportunity.
Other industries you might be interested in
Recent Biotech Stocks Articles
5 Red-Hot Biotech Stocks
The bricks are coming off the market's shoulders, and these five hot biotech stocks are among the top beneficiaries.
Hide Out from Volatility in … Biotech?
On April 19, Zafgen sold six million shares, one million more than initially planned.
4 Biotech Stocks to Buy
If this August is like most Augusts, the overall market isn't going to perform well for the next few weeks; biotech stocks may be the only worthwhile stocks to buy
Pfizer, Merck Stock – Same Ol’ Slumping Revenues, Same Mixed Prospects
The loss of exclusivity on blockbuster drugs continued to weigh in the top line at both Pfizer and Merck in the most recent quarter.
3 Reasons Why Biogen Stock Is Still a Buy (BIIB)
Janet Yellen might think biotech valuations are stretched, but the Street thinks companies like Biogen (BIIB) are just worth the growth
3 Biotech Stocks That Belong in Your Portfolio
The recent pullback in biotech stocks is an opportunity for investors to appeal to both growth and value in this dynamic sector.
CLVS: Clovis Oncology Lung Cancer Drug Gets Breakthrough Therapy Designation
Clovis Oncology says the Food and Drug Administration has granted Breakthrough Therapy status to its new lung cancer drug, sending CLVS shares bouncing.
Dow Theory Buy Signal Confirmed
The industrials broke to a new closing high, putting the pressure on the bears.
AZN, PFE: Pfizer Confirms Interest in Buying AstraZeneca
Pfizer says it has approached AstraZeneca about a possible $100 billion merger deal, sending AZN stock surging in Monday trading.
2 Clear Signs That Biotechs and Pharmaceuticals Have Peaked
Pharmaceuticals and biotechs have been too hot for their own good, fueled by increasingly iffy M&A and an oddly high level of IPO activity.
CYTK: Cytokinetics Stock in Ugly Free Fall on ALS Drug Fail
Cytokinetics stock plunged 60% after CYTK revealed that its amyotrophic lateral sclerosis drug hadn't met the primary goal of a mid-stage clinical trial.
ABBV: AbbVie Beats Street on Soaring Humira Sales
Pharmaceutical-maker AbbVie posted first-quarter sales that beat estimates on surging sales of its Humira drug, sending ABBV stock higher.
Grass Pollen Allergy? New Grastek Pill From Merck Hits Shelves Soon
Merck says the U.S. Food and Drug Administration has approve the release of its Grastek grass pollen allergy drug, which will launch later this month.
3 Biotech Stocks That Could Keep Bombing
After years of unchecked rallying in biotech stocks, a correction is finally upon us. And as bad as things have been, the mean-reversion move could go even lower.
Pharmaceuticals Deals: QCOR Gets a Big Premium, Roche Goes Shopping
Monday's big pharmaceuticals deals included Mallinckrodt buying Questcor for $5.6B -- a 27% premium to QCOR stock -- and Roche picking up Ranbaxy.
MNKD Stock, Take Two: Volatility or Not, You Have to Like Afrezza
Unfortunately, a bet on MNKD stock right now isn't a bet on the potential of Afrezza. But sooner or later, these facts will be reflected in MannKind shares.
MNKD: Buy the Rumor, Sell the News
MannKind has much to be excited about today with Afrezza, but investors need to recognize a troubling pattern that could upend MNKD stock.
4 Ways Obamacare Will Affect Stocks
Obamacare is here to stay. That's good for some stocks, and horrible for others. Here's a look at the winners and losers.
Ready, Aim, Bargain Hunt
Those with a good risk tolerance should use the current weakness to buy high-quality, oversold stocks.
